The clinical promise of immunotherapy in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a heterogeneous disease with poorer outcomes compared to other breast cancer subtypes. Contributing to the worse prognosis in TNBC is the higher rates of relapse and rapid progression after relapse. Advances in targeted therapeutics and conventional chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Vikas, Praveen, Borcherding, Nicholas, Zhang, Weizhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292225/
https://www.ncbi.nlm.nih.gov/pubmed/30573992
http://dx.doi.org/10.2147/CMAR.S185176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292225/
https://www.ncbi.nlm.nih.gov/pubmed/30573992
http://dx.doi.org/10.2147/CMAR.S185176

Ejemplares similares